KalVista Pharmaceuticals, Inc.
Status: Publicly traded
Direct answer
KalVista Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker KALV.
KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: Sebetralstat for HAE and Factor XIIa. The company was founded by T. Andrew Crockett, Edward P....
Can you invest in KalVista Pharmaceuticals, Inc.?
Yes. KalVista Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker KALV.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for KalVista Pharmaceuticals, Inc.
Detailed equity research is provided by MarketSnap.